Riconoscimento del rischio residuo

作者: Claudio Rapezzi , Massimo Volpe

DOI:

关键词:

摘要:

参考文章(18)
Alawi A. Alsheikh-Ali, Prasad V. Maddukuri, Hui Han, Richard H. Karas, Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer: Insights From Large Randomized Statin Trials Journal of the American College of Cardiology. ,vol. 50, pp. 409- 418 ,(2007) , 10.1016/J.JACC.2007.02.073
H. Robert Superko, Spencer King, Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required Circulation. ,vol. 117, pp. 560- 568 ,(2008) , 10.1161/CIRCULATIONAHA.106.667428
Peter Libby, The forgotten majority: unfinished business in cardiovascular risk reduction. Journal of the American College of Cardiology. ,vol. 46, pp. 1225- 1228 ,(2005) , 10.1016/J.JACC.2005.07.006
Daniel J. Rader, Molecular regulation of HDL metabolism and function: implications for novel therapies Journal of Clinical Investigation. ,vol. 116, pp. 3090- 3100 ,(2006) , 10.1172/JCI30163
Nicholas J. Leeper, Reza Ardehali, Emil M. deGoma, Paul A. Heidenreich, Statin Use in Patients With Extremely Low Low-Density Lipoprotein Levels Is Associated With Improved Survival Circulation. ,vol. 116, pp. 613- 618 ,(2007) , 10.1161/CIRCULATIONAHA.107.694117
Alberto Zanchetti, Lennart Hansson, Denis Clement, Dag Elmfeldt, Stevo Julius, Telma Rosenthal, Bernard Waeber, Hans Wedel, THE HOT INVESTIGATORS, including F Portaluppi, None, Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? Journal of Hypertension. ,vol. 21, pp. 797- 804 ,(2003) , 10.1097/00004872-200304000-00024
Ramachandran S. Vasan, Martin G. Larson, Eric P. Leip, Jane C. Evans, Christopher J. O'Donnell, William B. Kannel, Daniel Levy, Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease The New England Journal of Medicine. ,vol. 345, pp. 1291- 1297 ,(2001) , 10.1056/NEJMOA003417